These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. In silico validation of coumarin derivatives as potential inhibitors against Main Protease, NSP10/NSP16-Methyltransferase, Phosphatase and Endoribonuclease of SARS CoV-2. Maurya AK, Mishra N. J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632 [Abstract] [Full Text] [Related]
7. Cheminformatics approach to identify andrographolide derivatives as dual inhibitors of methyltransferases (nsp14 and nsp16) of SARS-CoV-2. Thomas J, Ghosh A, Ranjan S, Satija J. Sci Rep; 2024 Apr 29; 14(1):9801. PubMed ID: 38684706 [Abstract] [Full Text] [Related]
9. Crystal structure of SARS-CoV-2 nsp10-nsp16 in complex with small molecule inhibitors, SS148 and WZ16. Klima M, Khalili Yazdi A, Li F, Chau I, Hajian T, Bolotokova A, Kaniskan HÜ, Han Y, Wang K, Li D, Luo M, Jin J, Boura E, Vedadi M. Protein Sci; 2022 Sep 29; 31(9):e4395. PubMed ID: 36040262 [Abstract] [Full Text] [Related]
11. In silico identification of potential SARS COV-2 2'-O-methyltransferase inhibitor: fragment-based screening approach and MM-PBSA calculations. El Hassab MA, Ibrahim TM, Shoun AA, Al-Rashood ST, Alkahtani HM, Alharbi A, Eskandrani RO, Eldehna WM. RSC Adv; 2021 Apr 26; 11(26):16026-16033. PubMed ID: 35481212 [Abstract] [Full Text] [Related]
12. Computational Analysis of SAM Analogs as Methyltransferase Inhibitors of nsp16/nsp10 Complex from SARS-CoV-2. Balieiro AM, Anunciação ELS, Costa CHS, Qayed WS, Silva JRA. Int J Mol Sci; 2022 Nov 12; 23(22):. PubMed ID: 36430451 [Abstract] [Full Text] [Related]
13. Identification and structural studies of natural inhibitors against SARS-CoV-2 viral RNA methyltransferase (NSP16). Kumar M, Roy A, Rawat RS, Alok A, Tetala KKR, Biswas NR, Kaur P, Kumar S. J Biomol Struct Dyn; 2022 Nov 12; 40(24):13965-13975. PubMed ID: 34766876 [Abstract] [Full Text] [Related]
14. Structure-Based Virtual Screening for Methyltransferase Inhibitors of SARS-CoV-2 nsp14 and nsp16. Wu K, Guo Y, Xu T, Huang W, Guo D, Cao L, Lei J. Molecules; 2024 May 15; 29(10):. PubMed ID: 38792173 [Abstract] [Full Text] [Related]
15. Identification of promising drug candidates against NSP16 of SARS-CoV-2 through computational drug repurposing study. Vijayan V, Pant P, Vikram N, Kaur P, Singh TP, Sharma S, Sharma P. J Biomol Struct Dyn; 2021 Oct 15; 39(17):6713-6727. PubMed ID: 32741322 [Abstract] [Full Text] [Related]
19. Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2. Mohammad A, Alshawaf E, Marafie SK, Abu-Farha M, Al-Mulla F, Abubaker J. Biomolecules; 2021 Apr 14; 11(4):. PubMed ID: 33919870 [Abstract] [Full Text] [Related]
20. Binding of the Methyl Donor S-Adenosyl-l-Methionine to Middle East Respiratory Syndrome Coronavirus 2'-O-Methyltransferase nsp16 Promotes Recruitment of the Allosteric Activator nsp10. Aouadi W, Blanjoie A, Vasseur JJ, Debart F, Canard B, Decroly E. J Virol; 2017 Mar 01; 91(5):. PubMed ID: 28031370 [Abstract] [Full Text] [Related] Page: [Next] [New Search]